Cart
sales@molnova.com
Scutellarein7-diglucuronide
CAS No. 150641-65-9
Scutellarein7-diglucuronide( ——— )
Catalog No. M38297 CAS No. 150641-65-9
Scutellarin-7-diglucosidic acid is a nature flavone isolated from purple leaves of Perilla ocimoides var. Crispa.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameScutellarein7-diglucuronide
-
NoteResearch use only, not for human use.
-
Brief DescriptionScutellarin-7-diglucosidic acid is a nature flavone isolated from purple leaves of Perilla ocimoides var. Crispa.
-
DescriptionScutellarin-7-diglucosidic acid is a nature flavone isolated from purple leaves of Perilla ocimoides var. Crispa.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number150641-65-9
-
Formula Weight638.48
-
Molecular FormulaC27H26O18
-
Purity>98% (HPLC)
-
SolubilityH2O : 6 mg/mL (9.40 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yoshida K, et al. Diglucuronoflavones from purple leaves of Perilla ocimoides. Phytochemistry. 1993 Jul;33(4):917-9. ?2. Makino T, et al. Inhibitory effect of decoction of Perilla frutescens on cultured murine mesangial cell proliferation and quantitative analysis of its active constituents. Planta Med. 2001 Feb;67(1):24-8. ?
molnova catalog
related products
-
PAR-1-selective pept...
PAR-1-selective peptide
-
[Nle13, Glu14] Motil...
[Nle13, Glu14] Motilin, human, porcine
-
Stressin I
Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration.
